Merit Medical Systems, Inc. (MMSI)
USD 97.13
(-1.89%)
USD 97.13
(-1.89%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 123.94 Million USD | 39.25% |
| 2022 | 87.56 Million USD | 43.74% |
| 2021 | 60.91 Million USD | 197.35% |
| 2020 | -62.57 Million USD | 4.77% |
| 2019 | -65.7 Million USD | -212.1% |
| 2018 | 58.61 Million USD | 77.26% |
| 2017 | 33.06 Million USD | -5.18% |
| 2016 | 34.87 Million USD | -7.1% |
| 2015 | 37.54 Million USD | -6.53% |
| 2014 | 40.16 Million USD | 44.25% |
| 2013 | 27.84 Million USD | -6.06% |
| 2012 | 29.64 Million USD | -10.69% |
| 2011 | 33.19 Million USD | 92.92% |
| 2010 | 17.2 Million USD | -47.62% |
| 2009 | 32.84 Million USD | 6.01% |
| 2008 | 30.98 Million USD | 34.89% |
| 2007 | 22.97 Million USD | 20.83% |
| 2006 | 19.01 Million USD | -19.18% |
| 2005 | 23.52 Million USD | -13.97% |
| 2004 | 27.34 Million USD | 6.67% |
| 2003 | 25.62 Million USD | 52.78% |
| 2002 | 16.77 Million USD | 68.77% |
| 2001 | 9.93 Million USD | 187.31% |
| 2000 | 3.45 Million USD | -43.29% |
| 1999 | 6.1 Million USD | 15.09% |
| 1998 | 5.3 Million USD | 96.3% |
| 1997 | 2.7 Million USD | -38.64% |
| 1996 | 4.4 Million USD | 76.0% |
| 1995 | 2.5 Million USD | 25.0% |
| 1994 | 2 Million USD | -23.08% |
| 1993 | 2.6 Million USD | 52.94% |
| 1992 | 1.7 Million USD | 13.33% |
| 1991 | 1.5 Million USD | 1400.0% |
| 1990 | 100 Thousand USD | 125.0% |
| 1989 | -400 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 37.26 Million USD | -18.05% |
| 2024 Q2 | 45.46 Million USD | 26.57% |
| 2024 Q1 | 35.92 Million USD | 9.69% |
| 2023 Q2 | 28.81 Million USD | 9.21% |
| 2023 Q3 | 35.13 Million USD | 21.95% |
| 2023 Q4 | 32.75 Million USD | -6.79% |
| 2023 FY | 121.93 Million USD | 39.25% |
| 2023 Q1 | 26.38 Million USD | -13.26% |
| 2022 Q4 | 30.41 Million USD | 63.03% |
| 2022 Q3 | 18.65 Million USD | -19.78% |
| 2022 Q2 | 23.25 Million USD | 52.67% |
| 2022 FY | 87.56 Million USD | 43.74% |
| 2022 Q1 | 15.23 Million USD | -30.43% |
| 2021 Q2 | 8.89 Million USD | -37.33% |
| 2021 Q3 | 15.93 Million USD | 79.1% |
| 2021 Q4 | 21.89 Million USD | 37.44% |
| 2021 FY | 60.91 Million USD | 197.35% |
| 2021 Q1 | 14.19 Million USD | -11.33% |
| 2020 Q1 | 1.36 Million USD | 139.95% |
| 2020 Q3 | 64 Thousand USD | 100.34% |
| 2020 Q4 | 16 Million USD | 24910.94% |
| 2020 FY | -62.57 Million USD | 4.77% |
| 2020 Q2 | -18.99 Million USD | -1494.64% |
| 2019 Q2 | 12.2 Million USD | 28.12% |
| 2019 Q3 | -2.88 Million USD | -123.61% |
| 2019 Q4 | -3.4 Million USD | -18.33% |
| 2019 FY | -65.7 Million USD | -212.1% |
| 2019 Q1 | 9.52 Million USD | -30.3% |
| 2018 FY | 58.61 Million USD | 77.26% |
| 2018 Q2 | 15.11 Million USD | 72.12% |
| 2018 Q4 | 13.66 Million USD | -35.13% |
| 2018 Q1 | 8.78 Million USD | -33.57% |
| 2018 Q3 | 21.06 Million USD | 39.35% |
| 2017 Q3 | 879 Thousand USD | -93.42% |
| 2017 FY | 33.06 Million USD | -5.18% |
| 2017 Q4 | 13.21 Million USD | 1403.87% |
| 2017 Q2 | 13.36 Million USD | 138.22% |
| 2017 Q1 | 5.6 Million USD | -55.49% |
| 2016 Q4 | 12.6 Million USD | 321.86% |
| 2016 Q1 | 7.7 Million USD | -4.27% |
| 2016 Q2 | 11.58 Million USD | 50.29% |
| 2016 Q3 | 2.98 Million USD | -74.21% |
| 2016 FY | 34.87 Million USD | -7.1% |
| 2015 FY | 37.54 Million USD | -6.53% |
| 2015 Q2 | 12.24 Million USD | 40.65% |
| 2015 Q4 | 8.05 Million USD | -5.81% |
| 2015 Q1 | 8.7 Million USD | -38.78% |
| 2015 Q3 | 8.54 Million USD | -30.18% |
| 2014 Q4 | 14.21 Million USD | 17.73% |
| 2014 Q3 | 12.07 Million USD | 63.54% |
| 2014 Q2 | 7.38 Million USD | 13.79% |
| 2014 FY | 40.16 Million USD | 44.25% |
| 2014 Q1 | 6.48 Million USD | -40.56% |
| 2013 Q2 | 6.78 Million USD | 285.89% |
| 2013 FY | 27.84 Million USD | -6.06% |
| 2013 Q4 | 10.91 Million USD | 30.09% |
| 2013 Q1 | 1.75 Million USD | -59.42% |
| 2013 Q3 | 8.39 Million USD | 23.76% |
| 2012 Q3 | 9.08 Million USD | 10.46% |
| 2012 Q4 | 4.33 Million USD | -52.32% |
| 2012 Q2 | 8.22 Million USD | 2.69% |
| 2012 Q1 | 8 Million USD | 42.32% |
| 2012 FY | 29.64 Million USD | -10.69% |
| 2011 Q1 | 10.21 Million USD | 84.86% |
| 2011 Q3 | 6.5 Million USD | -40.01% |
| 2011 FY | 33.19 Million USD | 92.92% |
| 2011 Q2 | 10.84 Million USD | 6.24% |
| 2011 Q4 | 5.62 Million USD | -13.54% |
| 2010 FY | 17.2 Million USD | -47.62% |
| 2010 Q2 | 8.77 Million USD | 38.31% |
| 2010 Q3 | -3.44 Million USD | -139.22% |
| 2010 Q4 | 5.52 Million USD | 260.46% |
| 2010 Q1 | 6.34 Million USD | -15.62% |
| 2009 Q4 | 7.52 Million USD | -11.13% |
| 2009 FY | 32.84 Million USD | 6.01% |
| 2009 Q1 | 7.9 Million USD | -3.68% |
| 2009 Q2 | 8.96 Million USD | 13.46% |
| 2009 Q3 | 8.46 Million USD | -5.58% |
| 2008 Q2 | 9 Million USD | 36.42% |
| 2008 Q3 | 7.16 Million USD | -20.42% |
| 2008 Q4 | 8.2 Million USD | 14.41% |
| 2008 FY | 30.98 Million USD | 34.89% |
| 2008 Q1 | 6.6 Million USD | -4.75% |
| 2007 Q2 | 5.47 Million USD | 22.15% |
| 2007 Q4 | 6.93 Million USD | 13.92% |
| 2007 FY | 22.97 Million USD | 20.83% |
| 2007 Q1 | 4.47 Million USD | -4.56% |
| 2007 Q3 | 6.08 Million USD | 11.24% |
| 2006 Q1 | 3.73 Million USD | -27.1% |
| 2006 Q2 | 5.47 Million USD | 46.65% |
| 2006 Q3 | 5.13 Million USD | -6.21% |
| 2006 Q4 | 4.69 Million USD | -8.63% |
| 2006 FY | 19.01 Million USD | -19.18% |
| 2005 Q4 | 5.12 Million USD | 2.36% |
| 2005 Q3 | 5 Million USD | -30.37% |
| 2005 Q2 | 7.18 Million USD | 15.79% |
| 2005 Q1 | 6.2 Million USD | -5.51% |
| 2005 FY | 23.52 Million USD | -13.97% |
| 2004 Q2 | 7.94 Million USD | 18.41% |
| 2004 Q3 | 6.12 Million USD | -22.85% |
| 2004 Q4 | 6.56 Million USD | 7.23% |
| 2004 FY | 27.34 Million USD | 6.67% |
| 2004 Q1 | 6.7 Million USD | -7.23% |
| 2003 Q1 | 4.96 Million USD | 8.79% |
| 2003 FY | 25.62 Million USD | 52.78% |
| 2003 Q2 | 6.35 Million USD | 27.92% |
| 2003 Q4 | 7.22 Million USD | 2.03% |
| 2003 Q3 | 7.08 Million USD | 11.54% |
| 2002 Q4 | 4.56 Million USD | -1.29% |
| 2002 Q1 | 3.48 Million USD | 18.12% |
| 2002 Q2 | 4.1 Million USD | 17.82% |
| 2002 Q3 | 4.62 Million USD | 12.67% |
| 2002 FY | 16.77 Million USD | 68.77% |
| 2001 Q3 | 2.73 Million USD | 25.4% |
| 2001 Q4 | 2.94 Million USD | 8.0% |
| 2001 Q2 | 2.17 Million USD | 4.51% |
| 2001 FY | 9.93 Million USD | 187.31% |
| 2001 Q1 | 2.08 Million USD | 104.17% |
| 2000 Q3 | 1.22 Million USD | 89.07% |
| 2000 Q1 | 289.57 Thousand USD | -84.76% |
| 2000 Q2 | 647.69 Thousand USD | 123.67% |
| 2000 Q4 | 1.02 Million USD | -16.68% |
| 2000 FY | 3.45 Million USD | -43.29% |
| 1999 Q3 | 1.6 Million USD | 6.67% |
| 1999 Q1 | 1.1 Million USD | -15.38% |
| 1999 Q4 | 1.9 Million USD | 18.75% |
| 1999 Q2 | 1.5 Million USD | 36.36% |
| 1999 FY | 6.1 Million USD | 15.09% |
| 1998 Q3 | 1.5 Million USD | 15.38% |
| 1998 Q2 | 1.3 Million USD | 18.18% |
| 1998 Q1 | 1.1 Million USD | 37.5% |
| 1998 Q4 | 1.3 Million USD | -13.33% |
| 1998 FY | 5.3 Million USD | 96.3% |
| 1997 FY | 2.7 Million USD | -38.64% |
| 1997 Q1 | 600 Thousand USD | -33.33% |
| 1997 Q4 | 800 Thousand USD | 33.33% |
| 1997 Q3 | 600 Thousand USD | -25.0% |
| 1997 Q2 | 800 Thousand USD | 33.33% |
| 1996 Q2 | 1.1 Million USD | 0.0% |
| 1996 FY | 4.4 Million USD | 76.0% |
| 1996 Q3 | 1.4 Million USD | 27.27% |
| 1996 Q4 | 900 Thousand USD | -35.71% |
| 1996 Q1 | 1.1 Million USD | 22.22% |
| 1995 FY | 2.5 Million USD | 25.0% |
| 1995 Q4 | 900 Thousand USD | -10.0% |
| 1995 Q3 | 1 Million USD | 100.0% |
| 1995 Q2 | 500 Thousand USD | 66.67% |
| 1995 Q1 | 300 Thousand USD | 250.0% |
| 1994 Q4 | -200 Thousand USD | -150.0% |
| 1994 FY | 2 Million USD | -23.08% |
| 1994 Q1 | 1 Million USD | 25.0% |
| 1994 Q2 | 800 Thousand USD | -20.0% |
| 1994 Q3 | 400 Thousand USD | -50.0% |
| 1993 Q2 | 500 Thousand USD | -37.5% |
| 1993 FY | 2.6 Million USD | 52.94% |
| 1993 Q1 | 800 Thousand USD | 60.0% |
| 1993 Q4 | 800 Thousand USD | 60.0% |
| 1993 Q3 | 500 Thousand USD | 0.0% |
| 1992 Q2 | 600 Thousand USD | 500.0% |
| 1992 Q1 | 100 Thousand USD | -80.0% |
| 1992 Q3 | 400 Thousand USD | -33.33% |
| 1992 FY | 1.7 Million USD | 13.33% |
| 1992 Q4 | 500 Thousand USD | 25.0% |
| 1991 FY | 1.5 Million USD | 1400.0% |
| 1991 Q1 | 2 Million USD | 176.92% |
| 1991 Q3 | 400 Thousand USD | -82.61% |
| 1991 Q4 | 500 Thousand USD | 25.0% |
| 1991 Q2 | 2.3 Million USD | 15.0% |
| 1990 Q1 | 600 Thousand USD | 140.0% |
| 1990 Q3 | 1.2 Million USD | 33.33% |
| 1990 Q4 | -2.6 Million USD | -316.67% |
| 1990 FY | 100 Thousand USD | 125.0% |
| 1990 Q2 | 900 Thousand USD | 50.0% |
| 1989 FY | -400 Thousand USD | 0.0% |
| 1989 Q4 | -1.5 Million USD | -475.0% |
| 1989 Q3 | 400 Thousand USD | 0.0% |
| 1989 Q1 | 400 Thousand USD | 0.0% |
| 1989 Q2 | 400 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -57.66 Million USD | 314.927% |
| AngioDynamics, Inc. | -97.71 Million USD | 226.838% |
| AtriCure, Inc. | -26.68 Million USD | 564.505% |
| Avinger, Inc. | -16.63 Million USD | 845.08% |
| Azenta, Inc. | -73.12 Million USD | 269.494% |
| BioLife Solutions, Inc. | -70.82 Million USD | 275.0% |
| The Cooper Companies, Inc. | 533.1 Million USD | 76.75% |
| Daxor Corporation | -177.07 Thousand USD | 70095.2% |
| Ekso Bionics Holdings, Inc. | -15.11 Million USD | 920.169% |
| Femasys Inc. | -14.5 Million USD | 954.29% |
| GlucoTrack, Inc. | -7.1 Million USD | 1844.707% |
| Harvard Bioscience, Inc. | 1.89 Million USD | -6444.034% |
| Hologic, Inc. | 882.6 Million USD | 85.957% |
| ICU Medical, Inc. | 22.82 Million USD | -443.019% |
| Intuitive Surgical, Inc. | 1.76 Billion USD | 92.985% |
| KORU Medical Systems, Inc. | -10.26 Million USD | 1306.857% |
| LeMaitre Vascular, Inc. | 37.08 Million USD | -234.243% |
| Innovative Eyewear, Inc. | -6.9 Million USD | 1896.149% |
| Innovative Eyewear, Inc. | -6.9 Million USD | 1896.149% |
| Masimo Corporation | 136.5 Million USD | 9.199% |
| Microbot Medical Inc. | -9.85 Million USD | 1357.676% |
| Meihua International Medical Technologies Co., Ltd. | 14.67 Million USD | -744.596% |
| Nephros, Inc. | -1.59 Million USD | 7880.54% |
| NovoCure Limited | -232.87 Million USD | 153.225% |
| NEXGEL, Inc. | -3.47 Million USD | 3664.682% |
| NEXGEL, Inc. | -3.47 Million USD | 3664.682% |
| Singular Genomics Systems, Inc. | -102.8 Million USD | 220.567% |
| OraSure Technologies, Inc. | 54.07 Million USD | -129.191% |
| Pro-Dex, Inc. | 7.17 Million USD | -1627.924% |
| Pulse Biosciences, Inc. | -43.57 Million USD | 384.445% |
| Predictive Oncology Inc. | -13.92 Million USD | 990.317% |
| Precision Optics Corporation, Inc. | -2.72 Million USD | 4649.517% |
| QuidelOrtho Corporation | 139.1 Million USD | 10.896% |
| Repligen Corporation | 54.57 Million USD | -127.103% |
| Sanara MedTech Inc. | -4.21 Million USD | 3040.439% |
| STAAR Surgical Company | 28.09 Million USD | -341.129% |
| Sharps Technology, Inc. | -10.12 Million USD | 1323.939% |
| Utah Medical Products, Inc. | 16.77 Million USD | -638.773% |
| DENTSPLY SIRONA Inc. | -85 Million USD | 245.816% |
| Jin Medical International Ltd. | 2.86 Million USD | -4222.73% |